Development of a factor V and thrombin inhibitor following partial hepatic resection and the use of topical thrombin concentrate.
Cruickshank
M K
MK
Department of Medicine, University Hospital, London, Ontario, Canada.
Black
J
J
Wall
W
W
D000230:Adenocarcinoma / Q000556:secondary / Q000601:surgery*; D000287:Administration, Topical; D000368:Aged; D000818:Animals; D002417:Cattle; D005165:Factor V / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D013917:Thrombin / Q000008:administration & dosage / Q000037:antagonists & inhibitors*
D005165:Factor V; D013917:Thrombin